Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Receivables - Other: 2023-2025

Historic Receivables - Other for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $1.6 million.

  • Upstream Bio's Receivables - Other rose 234.85% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 234.85%. This contributed to the annual value of $567,000 for FY2024, which is 310.87% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Receivables - Other is $1.6 million, which was down 4.86% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Receivables - Other ranged from a high of $1.7 million in Q2 2025 and a low of $138,000 during Q4 2023.
  • Moreover, its 3-year median value for Receivables - Other was $869,500 (2024), whereas its average is $948,833.
  • Data for Upstream Bio's Receivables - Other shows a peak YoY skyrocketed of 310.87% (in 2024) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Receivables - Other (Quarterly) stood at $138,000 in 2023, then soared by 310.87% to $567,000 in 2024, then spiked by 234.85% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.7 million for Q2 2025, and $1.2 million during Q1 2025.